Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia
Davidson, Bruce L. ; Tapson, Victor F. ; Irwin, Richard S. ; French, Cynthia L. ; Elliott, C. Gregory ; Levi, Marcel
Citations
Student Authors
Faculty Advisor
Academic Program
Document Type
Publication Date
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Antiseptic mouthwash use to control coronavirus disease 2019 (COVID-19) has been proposed, disputed, and dismissed without understanding the proposal and without serious consideration of merits and counterarguments. Adding a proven, safe, and evidence-based clinically reasonable measure to existing approaches of universal masking and social distancing, while awaiting a safe and effective vaccine, seems a constructive approach worth implementing and observing for efficacy. We describe how adding pharyngeal antisepsis, “washing the throat,” before sleeping, when healthy adults of all ages aspirate material from above the larynx, can help protect individuals against COVID-19 pneumonia and, hence, help protect society. We also address critiques presented against widespread adoption of pharyngeal antisepsis.
Source
Davidson BL, Tapson VF, Irwin RS, French CL, Elliott CG, Levi M. Pharyngeal Antisepsis to Reduce COVID-19 Pneumonia. Am J Med. 2020 Dec 15:S0002-9343(20)31114-1. doi: 10.1016/j.amjmed.2020.12.001. Epub ahead of print. PMID: 33338507. Link to article on publisher's site